COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 229 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q2 2024. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,767,400 | -73.1% | 117,000 | -67.6% | 0.16% | -64.6% |
| Q1 2024 | $14,029,548 | +26.1% | 361,400 | +0.0% | 0.45% | +11.6% |
| Q4 2023 | $11,122,753 | +42.1% | 361,363 | +3.2% | 0.40% | +28.6% |
| Q3 2023 | $7,826,970 | +2.9% | 350,200 | -1.1% | 0.32% | +18.4% |
| Q2 2023 | $7,609,609 | -17.7% | 354,100 | -8.1% | 0.27% | -13.4% |
| Q1 2023 | $9,248,145 | +951.8% | 385,500 | +917.2% | 0.31% | +1515.8% |
| Q4 2022 | $879,234 | -95.0% | 37,898 | -94.9% | 0.02% | -96.1% |
| Q1 2021 | $17,538,000 | -29.3% | 740,000 | -40.3% | 0.48% | -39.8% |
| Q4 2020 | $24,817,000 | +19.2% | 1,239,000 | +23.9% | 0.81% | -16.6% |
| Q3 2020 | $20,828,000 | +7392.1% | 1,000,400 | +5784.7% | 0.97% | +2442.1% |
| Q1 2020 | $278,000 | -92.5% | 17,000 | -90.6% | 0.04% | -98.4% |
| Q4 2019 | $3,704,000 | – | 180,000 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $2,364,000 | 4.71% |
| GREAT POINT PARTNERS LLC | 861,410 | $20,364,000 | 4.27% |
| Rubric Capital Management LP | 2,420,214 | $57,214,000 | 3.60% |
| Camber Capital Management LP | 2,000,000 | $47,280,000 | 1.59% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 416,244 | $9,840,000 | 1.10% |
| Eventide Asset Management | 2,629,593 | $62,164,000 | 0.84% |
| RICE HALL JAMES & ASSOCIATES, LLC | 799,298 | $18,895,000 | 0.67% |
| EMERALD ADVISERS, LLC | 741,278 | $17,524,000 | 0.64% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 790,391 | $18,685,000 | 0.61% |
| Values First Advisors, Inc. | 37,222 | $880,000 | 0.60% |